Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Seattle Genetics, Inc.
Scientific Title
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in the Frontline Treatment of Patients With CD30-positive Mature T-cell Lymphomas